Special Safety Considerations: Immunogenicity monitoring, drug-drug interaction studies, biomarker safety assessment...
Domain: D05 - Clinical Trials PV Type: Knowledge Proficiency Level: L4 (Proficient - Independent practice) Bloom Level: Evaluate
Immunogenicity monitoring, drug-drug interaction studies, biomarker safety assessment
When this skill is activated, Claude should:
Generated from PV KSB Framework v1.0 | 2025-12-31